Annual Current Assets
$12.32 M
+$8.16 M+196.21%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual total current assets is $12.32 million, with the most recent change of +$8.16 million (+196.21%) on December 31, 2023.
- During the last 3 years, CYTH annual current assets has fallen by -$1.73 million (-12.33%).
- CYTH annual current assets is now -36.62% below its all-time high of $19.44 million, reached on December 31, 2021.
Performance
CYTH Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$3.26 M
-$1.19 M-26.82%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly total current assets is $3.26 million, with the most recent change of -$1.19 million (-26.82%) on September 30, 2024.
- Over the past year, CYTH quarterly current assets has dropped by -$9.06 million (-73.56%).
- CYTH quarterly current assets is now -83.24% below its all-time high of $19.44 million, reached on December 31, 2021.
Performance
CYTH Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CYTH Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +196.2% | -73.6% |
3 y3 years | -12.3% | -73.6% |
5 y5 years | +344.8% | -73.6% |
CYTH Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -36.6% | +196.2% | -83.2% | at low |
5 y | 5-year | -36.6% | +211.2% | -83.2% | +56.0% |
alltime | all time | -36.6% | >+9999.0% | -83.2% | +4091.3% |
Cyclo Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $3.26 M(-26.8%) |
Jun 2024 | - | $4.45 M(-32.3%) |
Mar 2024 | - | $6.57 M(-46.7%) |
Dec 2023 | $929.30 K(+1539.0%) | $12.32 M(+123.5%) |
Sep 2023 | - | $5.51 M(+21.2%) |
Jun 2023 | - | $4.55 M(+13.9%) |
Mar 2023 | - | $3.99 M(-4.0%) |
Dec 2022 | $56.70 K(-32.9%) | $4.16 M(-50.6%) |
Sep 2022 | - | $8.42 M(-28.5%) |
Jun 2022 | - | $11.78 M(-25.7%) |
Mar 2022 | - | $15.85 M(-18.5%) |
Dec 2021 | $84.50 K(-38.6%) | $19.44 M(+76.8%) |
Sep 2021 | - | $10.99 M(-22.2%) |
Jun 2021 | - | $14.12 M(-21.6%) |
Mar 2021 | - | $18.02 M(+28.3%) |
Dec 2020 | $137.70 K(-11.3%) | $14.05 M(+253.7%) |
Sep 2020 | - | $3.97 M(+90.2%) |
Jun 2020 | - | $2.09 M(-0.4%) |
Mar 2020 | - | $2.10 M(-47.0%) |
Dec 2019 | $155.20 K(+4.7%) | $3.96 M(-30.4%) |
Sep 2019 | - | $5.69 M(-23.1%) |
Jun 2019 | - | $7.40 M(+338.7%) |
Mar 2019 | - | $1.69 M(-39.1%) |
Dec 2018 | $148.20 K(-23.2%) | $2.77 M(+61.9%) |
Sep 2018 | - | $1.71 M(-19.3%) |
Jun 2018 | - | $2.12 M(+75.0%) |
Mar 2018 | - | $1.21 M(-36.1%) |
Dec 2017 | $192.90 K(-17.2%) | $1.90 M(-3.5%) |
Sep 2017 | - | $1.97 M(-0.9%) |
Jun 2017 | - | $1.98 M(-19.3%) |
Mar 2017 | - | $2.46 M(+50.2%) |
Dec 2016 | $233.00 K(-89.5%) | $1.64 M(-19.0%) |
Sep 2016 | - | $2.02 M(-29.7%) |
Jun 2016 | - | $2.87 M(+53.2%) |
Mar 2016 | - | $1.87 M(-25.8%) |
Dec 2015 | $2.22 M(-0.8%) | $2.52 M(-28.4%) |
Sep 2015 | - | $3.52 M(+66.7%) |
Jun 2015 | - | $2.11 M(-17.2%) |
Mar 2015 | - | $2.55 M(-16.3%) |
Dec 2014 | $2.24 M(+3.0%) | $3.05 M(-9.8%) |
Sep 2014 | - | $3.38 M(+83.7%) |
Jun 2014 | - | $1.84 M(+50.1%) |
Mar 2014 | - | $1.23 M(+98.1%) |
Dec 2013 | $2.17 M(-6.2%) | $618.90 K(-6.6%) |
Sep 2013 | - | $662.50 K(-20.0%) |
Jun 2013 | - | $828.30 K(+48.3%) |
Mar 2013 | - | $558.40 K(+83.6%) |
Dec 2012 | $2.31 M | $304.20 K(+10.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2012 | - | $275.20 K(-4.0%) |
Jun 2012 | - | $286.70 K(-27.7%) |
Mar 2012 | - | $396.60 K(+25.4%) |
Dec 2011 | $2.47 M(+58.0%) | $316.30 K(+17.7%) |
Sep 2011 | - | $268.80 K(-40.6%) |
Jun 2011 | - | $452.20 K(-27.7%) |
Mar 2011 | - | $625.40 K(+70.8%) |
Dec 2010 | $1.57 M(+114.2%) | $366.20 K(+14.4%) |
Sep 2010 | - | $320.20 K(-8.6%) |
Jun 2010 | - | $350.20 K(-31.3%) |
Mar 2010 | - | $510.10 K(-9.7%) |
Dec 2009 | $730.90 K(+2.2%) | $564.60 K(-2.4%) |
Sep 2009 | - | $578.50 K(+11.7%) |
Jun 2009 | - | $518.00 K(+0.6%) |
Mar 2009 | - | $515.00 K(-0.3%) |
Dec 2008 | $714.90 K(-29.7%) | $516.40 K(-12.7%) |
Sep 2008 | - | $591.50 K(+16.3%) |
Jun 2008 | - | $508.50 K(-9.0%) |
Mar 2008 | - | $559.00 K(-3.8%) |
Dec 2007 | $1.02 M(+132.1%) | $581.30 K(+6.3%) |
Sep 2007 | - | $547.10 K(+25.9%) |
Jun 2007 | - | $434.70 K(+21.5%) |
Mar 2007 | - | $357.90 K(+11.1%) |
Dec 2006 | $438.30 K(-9.8%) | $322.10 K(+26.2%) |
Sep 2006 | - | $255.20 K(-11.0%) |
Jun 2006 | - | $286.60 K(-21.2%) |
Mar 2006 | - | $363.60 K(+30.6%) |
Dec 2005 | $485.90 K(-34.2%) | $278.40 K(-16.7%) |
Sep 2005 | - | $334.10 K(+11.7%) |
Jun 2005 | - | $299.20 K(-4.4%) |
Mar 2005 | - | $312.90 K(+15.1%) |
Dec 2004 | $738.10 K(+24.3%) | $271.80 K(+6.3%) |
Sep 2004 | - | $255.60 K(+9.7%) |
Jun 2004 | - | $233.00 K(-24.8%) |
Mar 2004 | - | $310.00 K(+15.2%) |
Dec 2003 | $593.80 K(+73.1%) | $269.20 K(+75.0%) |
Sep 2003 | - | $153.80 K(+20.1%) |
Jun 2003 | - | $128.10 K(-1.9%) |
Mar 2003 | - | $130.60 K(-11.0%) |
Dec 2002 | $343.10 K(-12.1%) | $146.70 K(-29.4%) |
Sep 2002 | - | $207.90 K(+20.2%) |
Jun 2002 | - | $172.90 K(+7.9%) |
Mar 2002 | - | $160.20 K(+106.2%) |
Dec 2001 | $390.50 K(-13.9%) | $77.70 K(-11.4%) |
Sep 2001 | - | $87.70 K(-34.3%) |
Jun 2001 | - | $133.40 K(+9.0%) |
Mar 2001 | - | $122.40 K(+24.5%) |
Dec 2000 | $453.50 K | $98.30 K(-42.4%) |
Sep 2000 | - | $170.70 K |
FAQ
- What is Cyclo Therapeutics annual total current assets?
- What is the all time high annual current assets for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual current assets year-on-year change?
- What is Cyclo Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly current assets year-on-year change?
What is Cyclo Therapeutics annual total current assets?
The current annual current assets of CYTH is $12.32 M
What is the all time high annual current assets for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual total current assets is $19.44 M
What is Cyclo Therapeutics annual current assets year-on-year change?
Over the past year, CYTH annual total current assets has changed by +$8.16 M (+196.21%)
What is Cyclo Therapeutics quarterly total current assets?
The current quarterly current assets of CYTH is $3.26 M
What is the all time high quarterly current assets for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly total current assets is $19.44 M
What is Cyclo Therapeutics quarterly current assets year-on-year change?
Over the past year, CYTH quarterly total current assets has changed by -$9.06 M (-73.56%)